Skip to main content
SpringerLink
Log in

How common is rhabdomyolysis in patients receiving lipid-lowering therapy?

  • Practice Point
  • Published:

From Nature Clinical Practice Cardiovascular Medicine

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Grundy SM et al. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. J Am Coll Cardiol 44: 720–732

    Article  Google Scholar 

  2. Foley KA et al. (2004) Effectiveness of statin titration on Low-Density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events. Am J Cardiol 92: 79–81

    Article  Google Scholar 

  3. Pasternak RC et al. (2002) ACC/AHA/NHLBI Clinical advisory on the use and safety of statins. J Am Coll Cardiol 40: 567–572

    Article  Google Scholar 

  4. Gaist D et al. (2001) Lipid-lowering drugs and risk of myopathy: a population-based follow-up study. Epidemiology 12: 565–569

    Article  CAS  Google Scholar 

  5. Phillips PS et al. and the Scripps Mercy Clinical Research Center (2004) Statin Myotoxicity is Associated with Changes in the Respiratory Exchange Ratio. Atherosclerosis 177: 183–188

    Article  CAS  Google Scholar 

  6. Kordas KC et al. (2004) Clinical characteristics of 1053 patients with statin associated muscle complaints [abstract]. Arterioscler Thromb Vasc Biol 24: e51–e136

    Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Interventional Cardiology and Cardiology Research at Scripps Mercy Hospital,

    Paul S Phillips

  2. University of California, San Diego

    Paul S Phillips

  3. Skaggs Clinical Research Scholar at the Scripps Research Institute, San Diego, CA, USA

    Paul S Phillips

Authors
  1. Paul S Phillips
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul S Phillips.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Phillips, P. How common is rhabdomyolysis in patients receiving lipid-lowering therapy?. Nat Rev Cardiol 2, 130–131 (2005). https://doi.org/10.1038/ncpcardio0125

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0125

  • Springer Nature Limited

This article is cited by

Search

Navigation